Samuelsson K S, Egenvall M, Klarin I, Lökk J, Gunnarsson U
Department of Clinical Science, Intervention and Technology, CLINTEC, Stockholm, Sweden.
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Colorectal Dis. 2016 Feb;18(2):155-62. doi: 10.1111/codi.13077.
The study aimed to investigate whether continuing potentially inappropriate medication (PIM) is associated with length of hospital stay (LOS) and postoperative mortality in elderly people undergoing colorectal cancer surgery.
The Swedish National Colorectal Cancer Register and the Swedish Prescribed Drug Register provided matched data on 7279 patients aged 75 years or more who had undergone bowel resection for colorectal cancer between 2007 and 2010. Patients were divided into two groups depending on whether or not they were taking PIM at the time of surgery. The primary efficacy variables were the LOS and 30-day postoperative mortality.
Of the 7279 patients, 22.5% (1641) of the patients were exposed to at least one PIM and the total number of drugs taken in this group was six, compared with three in the non-PIM group (P < 0.001). Postoperative mortality was higher in the PIM group (7.1% vs 4.5%, P < 0.001), and LOS was longer (10 days vs 9, P = 0.001). When adjusted for independent predictors, the differences in LOS (odds ratio 1.14; 95% confidence interval 1.00-1.29, P = 0.046) and postoperative mortality (odds ratio 1.43; 95% confidence interval 1.11-1.85, P = 0.006) remained significant.
The use of PIM prior to surgery is associated with increased postoperative mortality and prolonged hospital stay. Although no causal relationship is proved, the results add a further aspect to preoperative optimization of elderly patients about to have major colorectal surgery.
本研究旨在调查持续使用潜在不适当药物(PIM)是否与接受结直肠癌手术的老年人的住院时间(LOS)和术后死亡率相关。
瑞典国家结直肠癌登记处和瑞典处方药登记处提供了2007年至2010年间7279例年龄在75岁及以上因结直肠癌接受肠切除术患者的匹配数据。根据患者在手术时是否服用PIM将其分为两组。主要疗效变量为住院时间和术后30天死亡率。
在7279例患者中,22.5%(1641例)患者至少使用了一种PIM,该组服用的药物总数为6种,而非PIM组为3种(P<0.001)。PIM组的术后死亡率更高(7.1%对4.5%,P<0.001),住院时间更长(10天对9天,P=0.001)。在对独立预测因素进行校正后,住院时间(优势比1.14;95%置信区间1.00-1.29,P=0.046)和术后死亡率(优势比1.43;95%置信区间1.11-1.85,P=0.006)的差异仍然显著。
术前使用PIM与术后死亡率增加和住院时间延长相关。虽然未证明因果关系,但研究结果为即将接受大型结直肠癌手术的老年患者术前优化提供了新的考量因素。